CME/CNE Information

Activity Title A Tale of Two Patients: Current and Future Approaches to MS Diagnosis and Treatment
Topic MS Diagnosis and Treatment
Accreditation Type AMA PRA Category 1 Credits™/ANCC Nursing Credits
Release Date July 2014
Expiration Date July 31, 2015 – No longer available for credit
Estimated Time to Complete Activity 60 minutes


Upon completion of the activity, participants should be able to:


Brenda L. Banwell, MD
Professor of Neurology and Pediatrics
University of Pennsylvania Perelman School of Medicine
Chief, Division of Neurology
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Director, Pediatric Multiple Sclerosis Clinic
The Hospital for Sick Children
Toronto, Ontario, Canada

Bryan D. Walker, MHS, PA-C
Assistant Professor
Associate Director of Didactic Curriculum
The George Washington University School of Medicine and Health Sciences
Washington, DC


  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CNE information.
  3. Complete the CME/CNE activity
  4. Complete the online posttest. A score of at least 70% is required to successfully complete this activity. The participant has 5 attempts to successfully pass.
  5. Complete the CME/CNE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Your CME/CNE certificate will be available for download


This site is best viewed using Internet Explorer 10.0 or higher, Google Chrome 35.0 or higher, Firefox 28.0 or higher. For interactive content, a broadband connection is required. For all CME/CNE activities featuring audio you must have a sound card and speakers.

Our interactive activities may require the Adobe Flash Player (available from the Adobe Web site) and Adobe Shockwave Player (available from the Adobe Web site). Both browser plug-ins are free.

Our activities may require JavaScript to be enabled on your computer.


Sponsored by The France Foundation and Nurse Practitioner Alternatives


This activity is intended for neurologists, nurse practitioners, nurses, case managers, social workers, and others involved in the care of patients with MS.


This activity is designed to improve the health care provider's understanding of the importance of biomarkers in the diagnosis and management of the patient with MS.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The France Foundation and Nurse Practitioner Alternatives. The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The France Foundation designates this enduring activity for a maximum 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APRNs.

Laurie Scudder DNP, NP, has served as Nurse Planner for this activity.


In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.


It is the policy of The France Foundation and NPA to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity will disclose to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation and NPA have identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The planners, reviewers, editors, and staff at Nurse Practitioners Alternatives who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosure

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME/CNE activity:


The France Foundation and NPA require CME/CNE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


This activity is supported by an educational grant from Teva CNS.


The France Foundation and NPA present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, NPA, and Teva assume no liability for the information herein.


Copyright © 2014 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at


If you have questions about this CME/CNE activity, please contact The France Foundation at 860-434-1650 or